Zobrazeno 1 - 2
of 2
pro vyhledávání: '"R Pellicer Voltas"'
Autor:
A Retamero Delgado, R Pellicer Voltas, E Salas Sanchez, A Carmona Yelo, D Conde Estevez, S Ortonobes Roig, E Gonzalez Colominas, B Lopez Garcia, O Ferrandez Quirante, D Echeverría Esnal
Publikováno v:
European Journal of Hospital Pharmacy. 21:A45.1-A45
Background A once-daily single-tablet regimen (STR) containing rilpivirine/emtricitabine/tenofovir (RPV/FTC/TDF) has been recently approved by the European Medicines Agency (EMA) for the treatment of treatment-naive HIV patients with a baseline viral
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a2c6c25d62bd65b6a5e704bc9ed922e5
https://doi.org/10.1136/ejhpharm-2013-000436.109
https://doi.org/10.1136/ejhpharm-2013-000436.109
Autor:
A Carmona Yelo, S Ortonobes Roig, B Lopez Garcia, E Fernandez Colominas, R Pellicer Voltas, O Ferrandez Quirantes
Publikováno v:
European Journal of Hospital Pharmacy. 20:A212.1-A212
Background Adefovir disoproxil (ADF) was the second nucleoside analogue to be approved for Hepatitis B Virus (HBV) treatment. Later studies showed that tenofovir had better and more cost effective clinical outcomes for HBV treatment. Purpose To analy
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::008a513cda0b35d64b0b6086791225de
https://doi.org/10.1136/ejhpharm-2013-000276.587
https://doi.org/10.1136/ejhpharm-2013-000276.587